A CDMO's Checklist For Prospective Clients: Part 1
In the world of Contract Development and Manufacturing Organizations (CDMOs), discussions often revolve around what clients should look for in a partner. However, there's an equally crucial aspect that deserves attention: what CDMOs seek from their prospective clients. While client checklists for selecting CDMOs are abundant, the perspective often neglects the vital reciprocal responsibilities necessary for a successful partnership.
In this three-part series, we explore the often-overlooked factors that contribute to a fruitful relationship between CDMOs and their clients. At the heart of this discussion lies transparency. Just as CDMOs are expected to be transparent in their operations and capabilities, clients must reciprocate with equal transparency. This introductory installment sets the stage for examining the pivotal role of transparency in fostering trust and collaboration between CDMOs and their clients.
In this first part, we delve into the importance of transparency in assessing process robustness—a cornerstone of the CDMO-client relationship. Join us as we unravel the intricacies of transparency in the dynamic world of pharmaceutical development and manufacturing partnerships.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.